<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2023.1272398</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Impact of gut microbiome on serum IgG4 levels in the general population: Shika-machi super preventive health examination results</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Koshida</surname>
<given-names>Aoi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Karashima</surname>
<given-names>Shigehiro</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/907119"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ogura</surname>
<given-names>Kohei</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/571772"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Miyajima</surname>
<given-names>Yuna</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ogai</surname>
<given-names>Kazuhiro</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mizoguchi</surname>
<given-names>Ren</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ikagawa</surname>
<given-names>Yasuo</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hara</surname>
<given-names>Satoshi</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1459922"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mizushima</surname>
<given-names>Ichiro</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1258288"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fujii</surname>
<given-names>Hiroshi</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kawano</surname>
<given-names>Mitsuhiro</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2070611"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tsujiguchi</surname>
<given-names>Hiromasa</given-names>
</name>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/944166"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hara</surname>
<given-names>Akinori</given-names>
</name>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nakamura</surname>
<given-names>Hiroyuki</given-names>
</name>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Okamoto</surname>
<given-names>Shigefumi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/574938"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Institute for Frontier Science Initiative, Kanazawa University</institution>, <addr-line>Kanazawa</addr-line>, <country>Japan</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Institute of Liberal Arts and Science, Kanazawa University</institution>, <addr-line>Kanazawa</addr-line>, <country>Japan</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Health Promotion and Medicine of the Future, Kanazawa University</institution>, <addr-line>Kanazawa</addr-line>, <country>Japan</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Clinical Laboratory Science, Faculty of Health Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University</institution>, <addr-line>Kanazawa</addr-line>, <country>Japan</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Department of Bio-engineering Nursing, Graduate School of Nursing, Ishikawa Prefectural Nursing University</institution>, <addr-line>Kahoku</addr-line>, <country>Japan</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Department of Rheumatology, Kanazawa University Hospital</institution>, <addr-line>Kanazawa</addr-line>, <country>Japan</country>
</aff>
<aff id="aff7">
<sup>7</sup>
<institution>Department of Hygiene and Public Health, Graduate School of Advanced Preventive Medical Sciences, Kanazawa University</institution>, <addr-line>Kanazawa</addr-line>, <country>Japan</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Xiangtian Yu, Shanghai Jiao Tong University, China</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Xin You, Peking Union Medical College Hospital (CAMS), China; Michiyo Matsumoto-Nakano, Okayama University, Japan</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Shigehiro Karashima, <email xlink:href="mailto:skarashima@staff.kanazawa-u.ac.jp">skarashima@staff.kanazawa-u.ac.jp</email>; Shigefumi Okamoto, <email xlink:href="mailto:sokamoto@sahs.med.osaka-u.ac.jp">sokamoto@sahs.med.osaka-u.ac.jp</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>16</day>
<month>10</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>13</volume>
<elocation-id>1272398</elocation-id>
<history>
<date date-type="received">
<day>04</day>
<month>08</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>09</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Koshida, Karashima, Ogura, Miyajima, Ogai, Mizoguchi, Ikagawa, Hara, Mizushima, Fujii, Kawano, Tsujiguchi, Hara, Nakamura and Okamoto</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Koshida, Karashima, Ogura, Miyajima, Ogai, Mizoguchi, Ikagawa, Hara, Mizushima, Fujii, Kawano, Tsujiguchi, Hara, Nakamura and Okamoto</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Introduction</title>
<p>Immunoglobulin G4 (IgG4) is a member of the human immunoglobulin G (IgG) subclass, a protein involved in immunity to pathogens and the body&#x2019;s resistance system. IgG4-related diseases (IgG4-RD) are intractable diseases in which IgG4 levels in the blood are elevated, causing inflammation in organs such as the liver, pancreas, and salivary glands. IgG4-RD are known to be more prevalent in males than in females, but the etiology remains to be elucidated. This study was conducted to investigate the relationship between gut microbiota (GM) and serum IgG4 levels in the general population.</p>
</sec>
<sec>
<title>Methods</title>
<p>In this study, the relationship between IgG4 levels and GM evaluated in male and female groups of the general population using causal inference. The study included 191 men and 207 women aged 40 years or older from Shika-machi, Ishikawa. GM DNA was analyzed for the 16S rRNA gene sequence using next-generation sequencing. Participants were bifurcated into high and low IgG4 groups, depending on median serum IgG4 levels.</p>
</sec>
<sec>
<title>Results</title>
<p>ANCOVA, Tukey&#x2019;s HSD, linear discriminant analysis effect size, least absolute shrinkage and selection operator logistic regression model, and correlation analysis revealed that <italic>Anaerostipes</italic>, <italic>Lachnospiraceae</italic>, <italic>Megasphaera</italic>, and <italic>[Eubacterium] hallii</italic> group were associated with IgG4 levels in women, while <italic>Megasphaera</italic>, <italic>[Eubacterium] hallii</italic> group, <italic>Faecalibacterium</italic>, <italic>Ruminococcus.</italic>1, and <italic>Romboutsia</italic> were associated with IgG4 levels in men. Linear non-Gaussian acyclic model indicated three genera, <italic>Megasphaera</italic>, <italic>[Eubacterium] hallii</italic> group, and <italic>Anaerostipes</italic>, and showed a presumed causal association with IgG4 levels in women.</p>
</sec>
<sec>
<title>Discussion</title>
<p>This differential impact of the GM on IgG4 levels based on sex is a novel and intriguing finding.</p>
</sec>
</abstract>
<kwd-group>
<kwd>
<italic>Megasphaera</italic>
</kwd>
<kwd>immunoglobulin G4</kwd>
<kwd>causal relationship</kwd>
<kwd>direct linear non-Gaussian acyclic model</kwd>
<kwd>gut microbiota</kwd>
<kwd>IgG4-related disease</kwd>
</kwd-group>
<counts>
<fig-count count="6"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="50"/>
<page-count count="11"/>
<word-count count="4734"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Intestinal Microbiome</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Immunoglobulin G4 (IgG4) is a protein involved in immunity and the body&#x2019;s resistance system against pathogens, such as bacteria and viruses (<xref ref-type="bibr" rid="B7">Davies and Sutton, 2015</xref>; <xref ref-type="bibr" rid="B23">Maslinska et&#xa0;al., 2022</xref>). Although IgG4 is the least common human Immunoglobulin G (IgG) subclass in the serum, IgG4-related diseases (IgG4-RD) are intractable diseases that result in elevated levels of IgG4 in the blood. These diseases cause swelling and inflammation in various tissues throughout the body, including organs like the liver, pancreas, kidneys, blood vessels, tear glands, and salivary glands (<xref ref-type="bibr" rid="B41">Wallace et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B37">Umehara et&#xa0;al., 2021</xref>). The development of IgG4-RD is characterized by the infiltration of lymphocytes, IgG4-positive plasma cells, and fibrosis, which leads to simultaneous or sequential swelling, nodules, and thickened lesions in multiple organs (<xref ref-type="bibr" rid="B20">Lu et&#xa0;al., 2021</xref>). The regulation of IgG4 production generally involves CD4 follicular T helper cells, T regulatory cells, and Th2 cells, with interleukin-4 (IL-4) and IL-13 promoting IgG4 and Immunoglobulin E (IgE) production (<xref ref-type="bibr" rid="B18">Lanzillotta et&#xa0;al., 2020</xref>). However, the underlying cause of elevated IgG4 levels remains unclear.</p>
<p>In recent years, there has been increasing attention in medical research towards the gut microbiota (GM). It has been found that the GM plays a crucial role in maintaining human health and influencing the development of diseases (<xref ref-type="bibr" rid="B6">Clemente et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B48">Yatsunenko et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B5">Chen et&#xa0;al., 2021</xref>). Additionally, the GM is involved in maintaining the delicate balance between host defense and immune tolerance and is believed to have a substantial impact on the pathogenesis of autoimmune diseases and allergies (<xref ref-type="bibr" rid="B48">Yatsunenko et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B14">Jiao et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B47">Xu et&#xa0;al., 2022</xref>). For instance, a human intervention study by Wastyk et&#xa0;al. showed that consuming highly fermented foods increased the diversity of the GM and reduced levels of inflammatory markers, such as IL-6 and IL-10 (<xref ref-type="bibr" rid="B44">Wastyk et&#xa0;al., 2021</xref>). Furthermore, Vujkovic-Cvijin et&#xa0;al. reported that GM is associated with an enhanced systemic IgG response, based on both human epidemiological and animal studies (<xref ref-type="bibr" rid="B40">Vujkovic-Cvijin et&#xa0;al., 2022</xref>). Furthermore, differences in GM composition ratios may mediate the activation of plasmacytoid dendritic cells to produce IFN-&#x3b1; and IL-33 and cause IgG4-RD (<xref ref-type="bibr" rid="B50">Yoshikawa et&#xa0;al., 2021</xref>).</p>
<p>To date, no studies have examined the causal relationship between GM and serum IgG4 levels in the general population. The GM varies widely according to sex (<xref ref-type="bibr" rid="B48">Yatsunenko et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B17">Koliada et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B49">Yoon et&#xa0;al., 2021</xref>). IgG4-RD has also been reported to show sex-related differences in terms of onset and treatment (<xref ref-type="bibr" rid="B43">Wang et&#xa0;al., 2019</xref>). The study hypothesized that gender differences in GM by gender might influence IgG4 levels, as they show gender differences with regard to the development and treatment of IgG4-RD. This study aimed to analyze GM of each male and female patients and use causal inferential methods to determine the relationship between IgG4 levels and GM in the general population.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<label>2</label>
<title>Materials and methods</title>
<sec id="s2_1">
<label>2.1</label>
<title>Participants</title>
<p>The participants were 398 residents (191 men and 207 women) aged 40 years or older, of Shika-machi, Hakui-gun, Ishikawa Prefecture, Japan, whose fecal samples were collected in 2019. The following five conditions were excluded from the analysis. 1) participants without measured serum IgG4 levels, 2) patients taking immunosuppressive drugs as described below; Methotrexate and Enbrel, 3) patients taking medications that significantly affect GM as described below; antibiotics, steroids, bowel regulators and antibacterial agents, proton pump inhibitor (PPI), 4) patients suspected cancer and IgG4-related disease, 5) individuals with missing data, 6) patients with inflammatory bowel disease (IBD).</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Data collection</title>
<p>Data from the Shika-machi Super Preventive Health Examination, a population survey aimed at establishing preventive methods for lifestyle-related diseases, were used. The survey was conducted between 2019. The four model districts selected from the Shika area were Horimatsu, Higashimasuho, Tsuchida, and Higashiki (<xref ref-type="bibr" rid="B16">Karashima et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B26">Nagase et&#xa0;al., 2020</xref>).</p>
<p>The Shika-machi Super Preventive Health Checkup data regarding parameters such as age, sex, medical history, medication status, allergy status, and alcohol consumption/smoking status were collected using a questionnaire. The body mass index (BMI) was calculated by dividing the current weight (kg) by the square of the height (m<sup>2</sup>). Venous blood was collected early in the morning after a 12-hour fast. The 24-hour urinary sodium excretion was calculated based on the 24-hour urinary creatinine and sodium excretion values (<xref ref-type="bibr" rid="B26">Nagase et&#xa0;al., 2020</xref>). The estimated daily salt intake was calculated using 24-hour urinary sodium excretion.</p>
<p>Immune-related blood samples were measured using the following test kits; IgG4 (IgG4 subclass BS-TIA3 IgG4, MEDICAL &amp; BIOLOGICAL LABORATORIES CO., LTD., Tokyo, Japan); Immunoglobulin G (IgG) (N-assay TIA IgG-SH Nittobo, NITTOBO MEDICAL CO., LTD., Tokyo, Japan); Immunoglobulin E (IgE) (ImmunoCAP Total IgE, THERMO FISHER SCIENTIFIC INC., Waltham, MA, USA); 50% hemolytic unit of complement (CH50) (auto CH50-L eikenII, DENKA COMPANY LIMITED, Tokyo, Japan); Anti-CCP antibody (Stacia MEBLux test CCP, MEDICAL &amp; BIOLOGICAL LABORATORIES CO., LTD., Tokyo, Japan); antinuclear antibody (ANA) (anti-nuclear antibody (ANA) (FA) [FR], FUJIREBIO INC., Tokyo, Japan); Aniti-SS-A/Ro antibody (stacia MEBLux test SS-A, MEDICAL &amp; BIOLOGICAL LABORATORIES CO., LTD., Tokyo, Japan); rheumatoid factor (RF) levels (LZtest &#x2018;eiken&#x2019; RF, EIKEN CHEMICAL CO., LTD., Tokyo, Japan).</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>DNA extraction and next-generation sequencing</title>
<p>Fecal samples were collected using previously described methods (<xref ref-type="bibr" rid="B24">Miyajima et&#xa0;al., 2022</xref>) and stored at &#x2212;80&#xb0;C until DNA extraction. The processing of fecal samples was carried out in a non-proliferation level 2 (P2) laboratory. The DNA extracted from the GM was processed to identify the 16S rRNA gene sequence using a previously reported next-generation sequencing method (<xref ref-type="bibr" rid="B24">Miyajima et&#xa0;al., 2022</xref>).</p>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Microbiome analysis</title>
<p>For microbiome analysis, QIIME2 software was used (<xref ref-type="bibr" rid="B4">Bolyen et&#xa0;al., 2022</xref>). Demultiplexed paired-end sequence data were denoised with DADA2, and the Silva 16S rRNA database (release 132) na&#xef;ve Bayes classifier was used for Amplicon Sequence Variant classification (<xref ref-type="bibr" rid="B29">Quast et&#xa0;al., 2013</xref>). Samples with fewer than 5000 sequences were removed from the analysis.</p>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>Statistical analysis</title>
<p>Statistical analysis and machine learning were performed using Python (version 3.10.9) (<xref ref-type="bibr" rid="B27">Pedregosa et&#xa0;al., 2011</xref>) or R, using R-studio (version 4.2.3, RStudio, Boston, MA, United States).</p>
<p>The clinical information of the participants underwent a normality assessment using the Shapiro-Wilk test. Normally distributed data are expressed as mean &#xb1; standard deviation, while non-normally distributed data are presented as median (25<sup>th</sup>&#x2013;75<sup>th</sup> percentile). The significance of differences in clinical information between the groups was assessed using Student&#x2019;s t-test for normally distributed data and the Wilcoxson rank-sum test for non-normally distributed data.</p>
<p>The patients were categorized into two groups, high and low, based on the median values of IgG4. Quade&#x2019;s non-parametric ANCOVA and Tukey&#x2019;s HSD test were used to compare the relative proportions of GM between the high and low IgG4 groups. Confounders such as age, sex, BMI, daily salt intake, frequency of alcohol consumption per week, and smoking were adjusted for (<xref ref-type="bibr" rid="B39">Vujkovic-Cvijin et&#xa0;al., 2020</xref>). Additionally, the clinical background variables that exhibited significant differences between the high and low IgG4 groups were included as new confounding factors. The significance level for all tests was set at <italic>P</italic> &lt; 0.05. Alpha diversity was evaluated using the Shannon index, with Amplicon Sequence Variant values (<xref ref-type="bibr" rid="B46">Willis, 2019</xref>). To assess the beta diversity, non-metric multidimensional scaling analysis with the Bray-Curtis dissimilarity metric from the &#x201c;vegan&#x201d; package in R was used, along with permutation multivariate analysis of variance (<xref ref-type="bibr" rid="B8">Dixon, 2003</xref>). To identify GM associated with IgG4, linear discriminant analysis effect size (LEfSe) was employed (<xref ref-type="bibr" rid="B30">Segata et&#xa0;al., 2011</xref>).</p>
<p>The odds ratios and <italic>P</italic>-values were calculated using the least absolute shrinkage and selection operator logistic regression model (LASSO logistic regression) from the &#x201c;glmnet&#x201d; package in R (<xref ref-type="bibr" rid="B35">Tibshirani, 1996</xref>). Multicollinearity was assessed using the variance expansion factor (VIF) and only bacterial genera with a VIF smaller than 10 were used in the LASSO analysis. Correlation coefficients and <italic>P</italic>-values were calculated using Spearman&#x2019;s rank correlation coefficient in R&#x2019;s &#x201c;Package ppcor&#x201d; after adjusting for the variables listed above. The correlation coefficients were plotted using &#x201c;Package pheatmap&#x201d;.</p>
<p>The heat maps were visualized as dendrograms using hierarchical clustering, which was based on similarity by correlation coefficient. Bacterial genera that were significantly correlated with IgG4 and one bacterial genus with the closest inter-cluster distance was set up as a new bacterial genus group. The closest bacterial genus was not grouped if it was a population of several bacterial genera.</p>
<p>The direct linear non-Gaussian acyclic model (LiNGAM) model was built using &#x201c;LiNGAM&#x201d; in Python (<xref ref-type="bibr" rid="B32">Shimizu et&#xa0;al., 2011</xref>). The bacterial genera chosen for LiNGAM algorithm were selected based on their significant associations identified in at least one of the following analyses: ANCOVA, Tukey&#x2019;s HSD, LEfSe, LASSO, and Correlation analyses. To demonstrate the robustness and consistency of the causal relationships, the occurrence rates and partial regression coefficients of the causal relationships were presented. Unselected bacterial genera were entered exhaustively as noise, and their impact on causality was observed (<xref ref-type="bibr" rid="B25">Mizoguchi et&#xa0;al., 2023</xref>).</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>Clinical background</title>
<p>Data on GM were procured from the fecal specimens of 234 study participants. The study dismissed 138 samples lacking IgG4 quantification, six individuals under immunosuppressive or gut flora-altering medications, one potential cancer case, and one suspected IgG4-RD case. None of the participants had IBD. In total, 88 patients (46 females and 42 males) participated in the analysis. <xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Figure&#xa0;1</bold>
</xref> contains a flowchart on sample selection. <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref> elucidates their clinical data. Participants were sorted into high and low categories based on their median serum IgG4 values. The median IgG4 value for all participants was 41.7 mg/dL. By gender, the median values stood at 34.8 mg/dL for females and 57.1 mg/dL for males. Significant discrepancies in BMI, IgG4, IgE, alcohol consumption, and smoking prevalence were observed between genders. <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Tables&#xa0;1</bold>
</xref>&#x2013;<xref ref-type="supplementary-material" rid="SM1">
<bold>3</bold>
</xref> respectively offer a comparative overview of the immunological landscape of high and low IgG4 cohorts of all participants, women and men, respectively.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Clinical characteristics of study participants categorized by sex.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="center"/>
<th valign="top" align="center">all</th>
<th valign="middle" align="center">female</th>
<th valign="middle" align="center">male</th>
<th valign="middle" align="center">
<italic>P</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="center">n</td>
<td valign="top" align="center">88</td>
<td valign="middle" align="center">46</td>
<td valign="middle" align="center">42</td>
<td valign="middle" align="center"/>
</tr>
<tr>
<td valign="middle" align="center">Age (years)</td>
<td valign="top" align="center">62 &#xb1; 11</td>
<td valign="middle" align="center">62 &#xb1; 10</td>
<td valign="middle" align="center">64 &#xb1; 11</td>
<td valign="middle" align="center">0.318</td>
</tr>
<tr>
<td valign="middle" align="center">BMI (kg/m2)</td>
<td valign="top" align="center">23.4 &#xb1; 3.0</td>
<td valign="middle" align="center">22.8 &#xb1; 3.3</td>
<td valign="middle" align="center">24.1 &#xb1; 2.6</td>
<td valign="middle" align="center">0.038</td>
</tr>
<tr>
<td valign="middle" align="center">IgG4 (mg/dl)</td>
<td valign="top" align="center">41.7 (23.8-76.2)</td>
<td valign="middle" align="center">34.8 (21.4-60.1)</td>
<td valign="middle" align="center">57.1 (31.4-81.5)</td>
<td valign="middle" align="center">0.013</td>
</tr>
<tr>
<td valign="middle" align="center">IgG (mg/dl)</td>
<td valign="top" align="center">1347.6 &#xb1; 269.8</td>
<td valign="middle" align="center">1355.0 &#xb1; 260.6</td>
<td valign="middle" align="center">1339.6 &#xb1; 279.3</td>
<td valign="middle" align="center">0.791</td>
</tr>
<tr>
<td valign="middle" align="center">IgE (IU/ml)</td>
<td valign="top" align="center">77.1 (31.2-170.8)</td>
<td valign="middle" align="center">48.2 (23.5-141.3)</td>
<td valign="middle" align="center">137 (47.6-253.3)</td>
<td valign="middle" align="center">0.003</td>
</tr>
<tr>
<td valign="middle" align="center">CH50 (U/ml)</td>
<td valign="top" align="center">43.9 (38.9-48.9)</td>
<td valign="middle" align="center">45.1 (40.3-49.9)</td>
<td valign="middle" align="center">42.2 (38.6-47.7)</td>
<td valign="middle" align="center">0.171</td>
</tr>
<tr>
<td valign="middle" align="center">Anti-CCP antibody (U/ml)</td>
<td valign="top" align="center">0.6 (0.6-0.6)</td>
<td valign="middle" align="center">0.6 (0.6-0.6)</td>
<td valign="middle" align="center">0.6 (0.6-0.6)</td>
<td valign="middle" align="center">0.891</td>
</tr>
<tr>
<td valign="middle" align="center">ANA (times)</td>
<td valign="top" align="center">40 (40-40)</td>
<td valign="middle" align="center">40 (40-40)</td>
<td valign="middle" align="center">40 (40-40)</td>
<td valign="middle" align="center">0.470</td>
</tr>
<tr>
<td valign="middle" align="center">Aniti-SS-A/Ro antibody (U/ml)</td>
<td valign="top" align="center">1 (1-1)</td>
<td valign="middle" align="center">1 (1-1)</td>
<td valign="middle" align="center">1 (1-1)</td>
<td valign="middle" align="center">0.187</td>
</tr>
<tr>
<td valign="middle" align="center">RF (IU/ml)</td>
<td valign="top" align="center">5 (5-8.5)</td>
<td valign="middle" align="center">5.5 (5-10.8)</td>
<td valign="middle" align="center">5 (5-8)</td>
<td valign="middle" align="center">0.229</td>
</tr>
<tr>
<td valign="middle" align="center">Allergy (%)</td>
<td valign="top" align="center">11.4</td>
<td valign="middle" align="center">10.9</td>
<td valign="middle" align="center">11.4</td>
<td valign="middle" align="center">0.880</td>
</tr>
<tr>
<td valign="middle" align="center">Alcohol consumption (day/week)</td>
<td valign="top" align="center">0 (0-4)</td>
<td valign="middle" align="center">0 (0-0.8)</td>
<td valign="middle" align="center">3 (0-7)</td>
<td valign="middle" align="center">&lt;0.001</td>
</tr>
<tr>
<td valign="middle" align="center">Salt intake (g/day)</td>
<td valign="top" align="center">9.2 (8.0-10.6)</td>
<td valign="middle" align="center">9.1 (8.3-10.3)</td>
<td valign="middle" align="center">9.6 (7.6-10.8)</td>
<td valign="middle" align="center">0.875</td>
</tr>
<tr>
<td valign="middle" align="center">Smoking (%)</td>
<td valign="top" align="center">19.3</td>
<td valign="middle" align="center">10.9</td>
<td valign="middle" align="center">27.9</td>
<td valign="middle" align="center">0.036</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>P values were calculated using covariance analysis (ANCOVA or Quade&#x2019;s nonparametric ANCOVA). ANCOVA, analysis of covariance; BMI, body mass index; CCP, cyclic citrullinated peptide; IgG4, Immunoglobulin G4; IgG, Immunoglobulin G; IgE, Immunoglobulin E; CH50, 50% hemolytic unit of complement; ANA, antinuclear antibody; RF, rheumatoid factor.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Comparison of gut microbiota composition</title>
<p>
<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref> displays stacked plots showing the mean relative abundance of the top 30 bacterial genera among women and men. The top 30 bacterial genera accounted for an average of 81% of women and 85% of men. <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1B</bold>
</xref> demonstrates the mean relative abundance of the top 30 genera in the high IgG4 and low IgG4 groups for all participants. Among female participants, the top 30 bacterial genera accounted for an average of 83% of the high IgG4 group and 83% of the low IgG4 group. When segregated by gender, they constituted 83% for both IgG4 groups among women (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>), while for men, they accounted for 82% and 62% in the high and low IgG4 groups, respectively (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1D</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Comparison of relative abundance ratios at the genus level for the top 30 bacterial genera with mean abundance ratios by sex <bold>(A)</bold>. Differences in gut microbiota between female and male groups. Differences in gut microbiota between high and low IgG4 groups in all participants <bold>(B)</bold>, women <bold>(C)</bold> and men <bold>(D)</bold>.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1272398-g001.tif"/>
</fig>
<p>
<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2A&#x2013;D</bold>
</xref> and <xref ref-type="fig" rid="f2">
<bold>2E&#x2013;H</bold>
</xref> depict the alpha and beta diversities, respectively, and the analyses revealed no significant disparities in gut GM diversity between sexes (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2A, E</bold>
</xref>) or among the high and low IgG4 groups (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2B&#x2013;D, F&#x2013;H</bold>
</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Comparison of gut microbiota diversity. Comparison between female and male groups. a-diversity (<bold>A</bold>; <italic>P</italic> = 0.534), &#x3b2;-diversity (<bold>E</bold>; <italic>P</italic> = 0.224) (<italic>P</italic> = 0.534). Red and blue indicate females and males, respectively. Comparison between the high and low IgG4 groups in all participants. a-diversity (<bold>B</bold>; <italic>P</italic> = 0.697), &#x3b2;-diversity (<bold>F</bold>; <italic>P</italic> = 0.706). Comparison between the high and low IgG4 groups in women. a-diversity (<bold>C</bold>; <italic>P</italic> = 0.537), &#x3b2;-diversity (<bold>G</bold>; <italic>P</italic> = 0.854). Comparison between men in the high and low IgG4 groups a-diversity (<bold>D</bold>; <italic>P</italic> = 0.224), &#x3b2;-diversity (<bold>H</bold>; <italic>P</italic> = 0.623),. Red indicates the high IgG4 group and blue indicates the low IgG4 group.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1272398-g002.tif"/>
</fig>
<p>
<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref> demonstrates the significant differences in the presence of specific bacterial genera between IgG4 groups and sexes: <italic>Anaerostipes</italic> were more prevalent in women than men (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>). In all participants, the proportion of <italic>Faecalibacterium</italic> present in the High IgG4 group was significantly lower than in the Low IgG4 group, and the proportion of <italic>Megasphaera</italic> present in the High IgG4 group was significantly higher than in the Low IgG4 group (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>). Women exhibited a significantly lower representation of <italic>Anaerostipes</italic> in the High IgG4 group (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>), while men in the High IgG4 group had significantly diminished proportions of <italic>Faecalibacterium</italic> and <italic>Ruminococcus.</italic>1 (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3D</bold>
</xref>).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Comparison of gut microbiota between groups. Comparison between men and women by ANCOVA <bold>(A)</bold>. Bacterial genera showing significant differences between high and low IgG4 groups in all participants <bold>(B)</bold>, women <bold>(C)</bold> and men <bold>(D)</bold>. Comparison between men and women by LEfSe <bold>(E)</bold>. Bacterial genera with Linear discriminant analysis (LDA) score of 2 or higher between high and low IgG4 groups in all participants <bold>(F)</bold> females <bold>(G)</bold>, and males.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1272398-g003.tif"/>
</fig>
<p>LEfSe revealed that the relative abundance of <italic>Blautia, Megamonas, Prevotella</italic> 9<italic>, Megasphaera, Ruminococcus.</italic>1<italic>, Anaerostipes, Subdoligranulum, Escherichia-Shigella</italic> has difference among women and men (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3E</bold>
</xref>). In all patients, the relative abundance of <italic>Megasphaera</italic> was higher in the high IgG4 group, and the relative abundances of <italic>Anaerostipes</italic> and <italic>Faecalibacterium</italic> were lower in the low IgG4 group (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3H</bold>
</xref>). In females, that of <italic>Lachnospiraceae</italic> was higher in the high IgG4 group (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3G</bold>
</xref>). In males, that of <italic>Megasphaera</italic> was higher in the high IgG4 group, and the relative abundance of <italic>Faecalibacterium</italic> and <italic>[Eubacterium] hallii</italic> group was lower in the low IgG4 group (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3H</bold>
</xref>).</p>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>LASSO model for predicting the classification of high and low IgG4 groups</title>
<p>A predictive model for classifying high/low IgG4 groups was developed using GM data in a LASSO logistic regression model. Thirteen bacterial genera (<italic>Blautia, Bifidobacterrium, Subdoligranulum, Streptococcus, Collinsella, Enterobacteriaceae, Fusicatenibacter,. [Eubacterium] hallii</italic> group, <italic>Anaerostipes, Veillonella, Romboutsia, Lactobacillus, and Ruminococcus.</italic>1) had VIF &lt;10 in all participants. In LASSO in all participants, none of the 13 bacterial genera had statistically significant odds ratios. The classification prediction model in all participants was the area under the receiver operating characteristic curve showed 0.658, sensitivity 0.750, and specificity 0.568 (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Receiver operating characteristic curve curves for LASSO analysis in all participants <bold>(A)</bold> and male <bold>(B)</bold>. In women, the LASSO model could not be applied because Parabacteroides was the only bacterial genus with a dispersal expansion coefficient below 10.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1272398-g004.tif"/>
</fig>
<p>Twelve bacterial genera (<italic>Blautia</italic>, <italic>Bifidobacterium</italic>, <italic>Parabacteroides</italic>, <italic>Collinsella</italic>, <italic>[Eubacterium] hallii</italic> group, <italic>Fusicatenibacter</italic>, <italic>[Eubacterium] coprostanoligenes</italic> group, <italic>Megasphaera</italic>, <italic>Anaerostipes</italic>, <italic>Veillonella</italic>, and <italic>Romboutsia</italic>) had VIF &lt;10 in male. Of the 12 bacterial genera, only <italic>Romboutsia</italic> was statistically significant with an odds ratio of 2.696 (95% confidence interval 1.031-7.050, P=0.043) (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;4</bold>
</xref>). The classification prediction model in males was the area under the receiver operating characteristic curve showed 0.907, sensitivity 0.857, and specificity 0.857 (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>). Only Parabacteroides had a VIF of less than 10, and other bacterial genera showed multicollinearity in women. For Parabacteroides alone, no predictive model could be built by LASSO and no ROC curve could be drawn.</p>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>Correlation and causality diagram between IgG4 and GM</title>
<p>
<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref> illustrates the correlation between IgG4 levels and the top 30 intestinal bacterial species, considering the relative abundance. <italic>Megasphaera</italic> and <italic>Lactobacillus</italic> displayed significant positive correlations with IgG4 levels in the entire cohort, while <italic>Faecalibacterium</italic> and <italic>[Eubacterium] hallii</italic> group exhibited significant negative correlations. In women, IgG4 levels were correlated positively with <italic>Megasphaera</italic> and negatively with <italic>[Eubacterium] hallii</italic> group. In men, a negative correlation was observed with <italic>Ruminococcus</italic>.1.</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Correlation between serum IgG4 levels and bacterial genera. Spearman&#x2019;s correlation coefficient, the color intensity of the heatmap is defined by Spearman&#x2019;s correlation coefficient. Hierarchical cluster analysis allowed relationships between bacteria to be visualized by dendrograms based on correlations with IgG4. (*: <italic>P</italic> &lt; 0.05).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1272398-g005.tif"/>
</fig>
<p>Based on the similarity of correlation coefficients between IgG4 values and bacterial genera visualized in a dendrogram, three groups were redefined: Group A encompassed <italic>Bifidobacterium</italic> and <italic>Lactobacillus</italic>; Group B incorporated <italic>Ruminococcus</italic>.1 and <italic>Ruminococcus</italic>.2; and Group C comprised the <italic>[Eubacterium] hallii</italic> group and <italic>Anaerostipes.</italic>
</p>
</sec>
<sec id="s3_5">
<label>3.5</label>
<title>Causal inference by LiNGAM model</title>
<p>Causal inference with the direct LiNGAM model using bacterial genera were significantly associated with IgG4 in ANCOVA, Tukey&#x2019;s HSD, LefSe, LASSO, and Correlation analyses.</p>
<p>
<xref ref-type="supplementary-material" rid="SF2">
<bold>Supplementary Figure&#xa0;2</bold>
</xref> shows the results of LiNGAM with bacterial genera and IgG4 listed in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;5</bold>
</xref>. No causal relationships were estimated between bacterial genera and IgG4.</p>
<p>
<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6</bold>
</xref> shows the estimated causal relationship with IgG4, including the redefined bacterial groups. In all participants and women, an increase in <italic>Megasphaera</italic> was also associated with an increase in serum IgG4 levels, while an increase in group C (<italic>[Eubacterium] hallii</italic> group and <italic>Anaerostipes</italic>) was associated with a decrease in serum IgG4 levels. In the robustness analysis of causal results, a causal direction from <italic>Megasphaera</italic> to IgG4 was detected in 82.6% of cases (partial regression coefficient 385.0 &#xb1; 45.9) and from group C to IgG4 in 78.3% of cases (partial regression coefficient -359.4 &#xb1; 62.9) in all participants. A causal direction from <italic>Megasphaera</italic> to IgG4 was detected in 81.8% of cases (partial regression coefficient 673.7 &#xb1; 73.7) and from group C to IgG4 in 59.1% of cases (partial regression coefficient -710.0 &#xb1; 84.3) in women. In contrast, no causal relationship between bacterial genus and IgG4 could be inferred in males.</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Causal inference between IgG4 levels and bacterial genus by GM group. Causal inference results are presented separately for all participants <bold>(A)</bold>, female participants <bold>(B)</bold> and male participants <bold>(C)</bold>. The arrows indicate the direction of causality between two connected indicators. Values are partial regression coefficients. Groups A, B, and C were grouped based on phylogenetic trees according to the correlation between bacterial genera and IgG4. Group A includes Bifidobacterium + Lactobacillus, Group B includes Ruminococcus.1 + Ruminococcus.2 and Group C includes [Eubacterium] hallii group + Anaerostipes. IgG4 is highlighted in blue, and bacterial genera and bacterial groups presumed to be causally related in each group are highlighted in pink.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1272398-g006.tif"/>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>Women had a significantly higher proportion of <italic>Anaerostipes</italic> than men in the general population. Causal inference in women showed that <italic>Megasphaera</italic> increased IgG4 levels, while the groups including <italic>[Eubacterium] hallii</italic> group and <italic>Anaerostipes</italic> decreased IgG4 levels. In men, <italic>Megasphaera</italic>, <italic>[Eubacterium] hallii</italic> group, <italic>Faecalibacterium</italic>, <italic>Ruminococcus.</italic>1, and <italic>Romboutsia</italic> were important bacterial genera for classifying high IgG4 groups and low IgG4 groups. No bacterial genera presented a causal relationship with serum IgG4 levels in men. Serum IgG4 levels may be associated with changes in the gut bacterial genera.</p>
<p>Several studies have reported on the association between IgG4-RD and GM (<xref ref-type="bibr" rid="B43">Wang et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B19">Liu et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B28">Plichta et&#xa0;al., 2021</xref>). Yoshikawa et&#xa0;al. reported that abnormalities in the GM mediate the activation of plasmacytoid dendritic cells, which produces IFN-&#x3b1; and IL-33, causing experimental autoimmune pancreatitis and IgG4-RD (<xref ref-type="bibr" rid="B43">Wang et&#xa0;al., 2019</xref>). Liu et&#xa0;al. also found that in IgG4-related sclerosing cholangitis, marked depletion of <italic>Blautia</italic> and elevated succinate may be responsible for hepatitis (<xref ref-type="bibr" rid="B19">Liu et&#xa0;al., 2021</xref>). These reports reinforce the relationship between GM and IgG4-RD development. However, the bacteria they reported were not entirely consistent with the bacterial genera in this study that identified the relationship.</p>
<p>
<italic>Megasphaer</italic>a is a genus of anaerobic bacteria that metabolizes short-chain fatty acids such as acetic, butyric, and isobutyric acid (<xref ref-type="bibr" rid="B13">Jeon et&#xa0;al., 2017</xref>). In the Japanese population, <italic>Megasphaera</italic> is more prevalent in males than in females (<xref ref-type="bibr" rid="B11">Hatayama et&#xa0;al., 2023</xref>). In our study, the LEfSe analysis also identified the proportion of <italic>Megasphaera</italic> composition as a significant bacterial flora characteristic distinguishing between men and women. Furusawa et&#xa0;al. reported that butyric acid produced by microorganisms induces the differentiation of regulatory T cells, which play a role in suppressing allergic reactions (<xref ref-type="bibr" rid="B10">Furusawa et&#xa0;al., 2013</xref>). Moreover, Dong et&#xa0;al. reported an association between <italic>Megasphaera</italic> and IgA nephropathy, in which IgA, a type of immunoglobulin, is deposited in the glomeruli (<xref ref-type="bibr" rid="B9">Dong et&#xa0;al., 2020</xref>).</p>
<p>The <italic>[Eubacterium] hallii</italic> group and <italic>Anaerostipes</italic> were categorized as closely related based on the similarity of their correlations with IgG4. Shetty et&#xa0;al. have demonstrated the close relationship between <italic>[Eubacterium] hallii</italic> group and <italic>Anaerostipes</italic> using a multifaceted approach and have recommended their reclassification (<xref ref-type="bibr" rid="B31">Shetty et&#xa0;al., 2018</xref>). They both can convert lactic acid to butyric acid, a short chain fatty acid, and may have similar functional roles in the gut (<xref ref-type="bibr" rid="B3">Belenguer et&#xa0;al., 2006</xref>). Additionally, <italic>[Eubacterium] hallii</italic> group was found to be enriched in the GM of patients with chronic inflammatory demyelinating polyneuritis, a chronic autoimmune disease affecting the peripheral nerves, compared to healthy subjects (<xref ref-type="bibr" rid="B33">Sva&#x10d;ina et&#xa0;al., 2023</xref>). Furthermore, the abundance of <italic>Anaerostipes</italic> was found to differ significantly between the immune antibody-positive and -negative groups in patients with immune antibody-positive-related repeated miscarriages (<xref ref-type="bibr" rid="B15">Jin et&#xa0;al., 2020</xref>).</p>
<p>These findings suggest a close relationship between IgG4-RD, immune diseases, and GM development and pathogenesis, which may be mediated by GM-derived short-chain fatty acids. Fatty acids play a crucial role in the differentiation of Th0 cells into TH2 cells, which are responsible for the release of interleukin-4 (IL-4) (<xref ref-type="bibr" rid="B2">Asarat et&#xa0;al., 2015</xref>). IL-4, IL-10, IL-21, IL-13, and B cell-activating factors have been found to be correlated with IgG4 production (<xref ref-type="bibr" rid="B22">Maehara et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B34">Tanaka et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B45">Watanabe et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B1">Akiyama et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B21">Maehara et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B18">Lanzillotta et&#xa0;al., 2020</xref>). Therefore, it is plausible that short-chain fatty acids may influence IgG4 production through their impact on inflammatory cytokines.</p>
<p>We have newly redefined bacterial groups based on the similarity of correlations of bacterial genera to IgG4. As gut bacteria are thought to interact with each other to create a favorable habitat, it is necessary to not only find a relationship between one bacterial genus and IgG4 but also to evaluate bacterial genera with similarities to each other. Both <italic>Lactobacilli</italic> and <italic>Bifidobacteria</italic> are non-spore-forming, gram-positive, lactic acid-producing bacteria. Despite some common properties, <italic>Lactobacilli</italic> and <italic>Bifidobacteria</italic> belong to two taxonomically distinct groups: the genus <italic>Lactobacillus</italic> in the phylum <italic>Firmicutes</italic> and the genus <italic>Bifidobacterium</italic> in the phylum <italic>Actinobacteria</italic>, respectively (<xref ref-type="bibr" rid="B38">Vlasova et&#xa0;al., 2016</xref>). <italic>Ruminococcus</italic>.1 and <italic>Ruminococcus</italic>.2 are also considered part of the phylum <italic>Bacillota</italic>, the <italic>Bacillota</italic> web, and the order <italic>Eubacteriales</italic> and are classified as <italic>Ruminococcus</italic>.1 and <italic>Ruminococcus</italic>.2 in the SILVA database (<xref ref-type="bibr" rid="B4">Bolyen et&#xa0;al., 2022</xref>). These combinations have been reported to show high genetic similarity by comparison of 16S rRNA sequences (<xref ref-type="bibr" rid="B38">Vlasova et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B12">Henderson et&#xa0;al., 2019</xref>), therefore, it is reasonable to redefine them as a group. Direct LiNGAM inferred a causal relationship between bacterial genera and bacterial groups, but the complexity of gut-bacterial interactions is high and many aspects need to be clarified and require further research.</p>
<p>This study has several limitations that should be considered. Firstly, although the three bacterial genera <italic>Megasphaera</italic>, <italic>[Eubacterium] hallii</italic> group, and <italic>Anaerostipes</italic> identified in this study are known to produce butyrate, it cannot be definitively concluded that these bacteria are causally related to IgG4. Other SCFA-producing bacteria may also be involved, and the underlying mechanisms of action of these bacteria need further investigation. Secondly, lifestyle factors involved in IgG4-RD may not be adequately considered. Some researchers have argued that lifestyle habits, such as smoking, contribute to the development of IgG4-RD (<xref ref-type="bibr" rid="B42">Wallwork et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B36">Tsuji et&#xa0;al., 2023</xref>). The Direct LiNGAM model cannot correctly analyze for unobserved confounders. It cannot be ruled out that lifestyle differences based on gender may be a confounding factor for gut bacteria and high IgG4 levels. Further studies should therefore be conducted, e.g. in animal models that are unaffected by gender differences in lifestyle. Finally, it should be noted that the participants were not patients with IgG4-RD. However, no report has attempted to identify a causal relationship between GM and serum IgG4 levels in the general population, which underlines the importance of this study. Further studies are needed to clarify the influence of GM on IgG4-RD development.</p>
<p>In conclusion, <italic>Megasphaera</italic>, <italic>[Eubacterium] hallii</italic> group, and <italic>Anaerostipes</italic> were identified as bacterial species that potentially have a causal relationship with IgG4 levels in women. The fact that the impact of the GM on IgG4 levels differs according to gender is a novel and interesting finding. Particularly, the following two points should be considered with caution. (i) the results revealed in the present study, in which the proportion of <italic>Anaerostipes</italic> present in a suspected causal role in reducing IgG4 was significantly higher in women, and (ii) the previously reported fact that women have a lower incidence of IgG4-RD than men. These results may lead to a new hypothesis that women are less likely to develop IgG4-RD than men due to the abundance of <italic>Anaerostipes</italic> in the gut. To elucidate the pathogenesis of IgG4-RD of unknown cause, the metabolites derived from gut bacteria that regulate serum IgG4 levels need to be investigated in detail in the future.</p>
</sec>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The raw data of the sequencing was registered at DNA Data Bank of Japan (DDBJ) (Number DRA016467). <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;6</bold>
</xref> listed the BioSAMPLE IDs analyzed in the study.</p>
</sec>
<sec id="s7" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The studies involving humans were approved by the ethics committee for Human Studies at Kanazawa University Hospital. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.</p>
</sec>
<sec id="s8" sec-type="author-contributions">
<title>Author contributions</title>
<p>AK: Conceptualization, Data curation, Project administration, Validation, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. SK: Conceptualization, Funding acquisition, Methodology, Project administration, Supervision, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. KoO: Methodology, Validation, Writing &#x2013; review &amp; editing, Data curation. YM: Data curation, Investigation, Methodology, Validation, Writing &#x2013; review &amp; editing. KaO: Methodology, Writing &#x2013; review &amp; editing. RM: Data curation, Methodology, Validation, Writing &#x2013; review &amp; editing. YI: Methodology, Writing &#x2013; review &amp; editing. SH: Investigation, Writing &#x2013; review &amp; editing. IM: Investigation, Writing &#x2013; review &amp; editing. HF: Investigation, Writing &#x2013; review &amp; editing. MK: Investigation, Writing &#x2013; review &amp; editing. HT: Data curation, Writing &#x2013; review &amp; editing. AH: Investigation, Writing &#x2013; review &amp; editing. HN: Writing &#x2013; review &amp; editing, Investigation. SO: Funding acquisition, Investigation, Supervision, Writing &#x2013; review &amp; editing.</p>
</sec>
</body>
<back>
<sec id="s9" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was supported by a grant from JSPS KAKENHI [grant numbers 22K197060 to SO, and JP19K17956 and JP21K10392 to SK] and Yakult Bio-Science Foundation. The funder financed the study experiments as well as the writing and proofreading of this manuscript.</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>We thank Editage (Tokyo, Japan; <ext-link ext-link-type="uri" xlink:href="http://www.editage.jp">www.editage.jp</ext-link>) for the English language editing.</p>
</ack>
<sec id="s10" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s11" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s12" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcimb.2023.1272398/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcimb.2023.1272398/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Image_1.jpeg" id="SF1" mimetype="image/jpeg"/>
<supplementary-material xlink:href="Image_2.jpeg" id="SF2" mimetype="image/jpeg"/>
<supplementary-material xlink:href="DataSheet_1.pdf" id="SM1" mimetype="application/pdf"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akiyama</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Yasuoka</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Yoshimoto</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Takeuchi</surname> <given-names>T.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Interleukin-4 contributes to the shift of balance of IgG subclasses toward IgG4 in IgG4-related disease</article-title>. <source>Cytokine</source> <volume>110</volume>, <fpage>416</fpage>&#x2013;<lpage>419</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cyto.2018.05.009</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Asarat</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Apostolopoulos</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Vasiljevic</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Donkor</surname> <given-names>O.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Short-chain fatty acids produced by synbiotic mixtures in skim milk differentially regulate proliferation and cytokine production in peripheral blood mononuclear cells</article-title>. <source>Int. Food. Sci. Nutr.</source> <volume>66</volume> (<issue>7</issue>), <fpage>755</fpage>&#x2013;<lpage>765</lpage>. doi: <pub-id pub-id-type="doi">10.3109/09637486.2015.1088935</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Belenguer</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Duncan</surname> <given-names>S. H.</given-names>
</name>
<name>
<surname>Calder</surname> <given-names>A. G.</given-names>
</name>
<name>
<surname>Holtrop</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Louis</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Flint</surname> <given-names>H. J.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>72</volume> (<issue>5</issue>), <fpage>3593</fpage>&#x2013;<lpage>3599</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AEM.72.5.3593-3599.2006</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="web">
<person-group person-group-type="author">
<name>
<surname>Bolyen</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Rideout</surname> <given-names>J. R.</given-names>
</name>
<name>
<surname>Dillon</surname> <given-names>M. R.</given-names>
</name>
<name>
<surname>Bokulich</surname> <given-names>N. A.</given-names>
</name>
<name>
<surname>Abnet</surname> <given-names>C. C.</given-names>
</name>
<name>
<surname>Al-Ghalith</surname> <given-names>G. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>QIIME 2 docs</article-title>. Available at: <uri xlink:href="https://docs.qiime2.org/2022.2/">https://docs.qiime2.org/2022.2/</uri>.</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Bai</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>D.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Role and mechanism of gut microbiota in human disease</article-title>. <source>Front. Cell. Infect. Microbiol.</source> <volume>11</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2021.625913</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clemente</surname> <given-names>J. C.</given-names>
</name>
<name>
<surname>Ursell</surname> <given-names>L. K.</given-names>
</name>
<name>
<surname>Parfrey</surname> <given-names>L. W.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>The impact of the gut microbiota on human health: an integrative view</article-title>. <source>Cell</source> <volume>148</volume> (<issue>6</issue>), <fpage>1258</fpage>&#x2013;<lpage>1270</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cell.2012.01.035</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davies</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Sutton</surname> <given-names>B. J.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Human IgG4: a structural perspective</article-title>. <source>Immunol. Rev.</source> <volume>268</volume>, <fpage>139</fpage>&#x2013;<lpage>159</lpage>. doi: <pub-id pub-id-type="doi">10.1111/imr.12349</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dixon</surname> <given-names>P.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>VEGAN, a package of R functions for community ecology</article-title>. <source>J. Veg Sci.</source> <volume>14</volume>, <fpage>927</fpage>&#x2013;<lpage>930</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1654-1103.2003.tb02228.x</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dong</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Bai</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Ning</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>A comparative study of the gut microbiota associated with immunoglobulin A nephropathy and membranous nephropathy</article-title>. <source>Front. Cell. Infection Microbiol.</source> <volume>10</volume>, <elocation-id>557368</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fcimb.2020.557368</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Furusawa</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Obata</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Fukuda</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Endo</surname> <given-names>T. A.</given-names>
</name>
<name>
<surname>Nakato</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Takahashi</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2013</year>). <article-title>Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells</article-title>. <source>Nature</source> <volume>504</volume>, <fpage>446</fpage>&#x2013;<lpage>450</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nature12721</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hatayama</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Sakamoto</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Fukushima</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Ishii</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Kawabata</surname> <given-names>H.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Sex differences in intestinal microbiota and their association with some diseases in a Japanese population observed by analysis using a large dataset</article-title>. <source>Biomedicines</source> <volume>11</volume> (<issue>2</issue>), <fpage>376</fpage>. doi: <pub-id pub-id-type="doi">10.3390/biomedicines11020376</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Henderson</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Yilmaz</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Kumar</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Forster</surname> <given-names>R. J.</given-names>
</name>
<name>
<surname>Kelly</surname> <given-names>W. J.</given-names>
</name>
<name>
<surname>Leahy</surname> <given-names>S. C.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Improved taxonomic assignment of rumen bacterial 16S rRNA sequences using a revised SILVA taxonomic framework</article-title>. <source>PeerJ</source> <volume>7</volume>, <elocation-id>e6496</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.7717/peerj.6496</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jeon</surname> <given-names>B. S.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>B. C.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>H. Y.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>S. Y.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>H. J.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>J. S.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Megasphaera hexanoica sp. nov., a medium-chain carboxylic acid-producing bacterium isolated from a cow rumen</article-title>. <source>Int. J. Syst. Evol. Microbiol.</source> <volume>67</volume> (<issue>7</issue>), <page-range>2114&#x2013;2120</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1099/ijsem.0.001888</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiao</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Huntington</surname> <given-names>N. D.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Crosstalk between gut microbiota and innate immunity and its implication in autoimmune diseases</article-title>. <source>Front. Immunol.</source> <volume>11</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2020.00282</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jin</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Qiu</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Ying</surname> <given-names>H.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Changes in gut microorganism in patients with positive immune antibody-associated recurrent abortion</article-title>. <source>BioMed. Res. Int.</source> <volume>2020</volume>, <fpage>4673250</fpage>. doi: <pub-id pub-id-type="doi">10.1155/2020/4673250</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karashima</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Kometani</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Tsujiguchi</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Asakura</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Nakano</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Usukura</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Prevalence of primary aldosteronism without hypertension in the general population: results in Shika study</article-title>. <source>Clin. Exp. Hypertens.</source> <volume>40</volume>, <fpage>118</fpage>&#x2013;<lpage>125</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/10641963.2017.1339072</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koliada</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Syzenko</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Moseiko</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Budovska</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Puchkov</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Perederiy</surname> <given-names>V.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Sex differences in the phylum-level human gut microbiota composition</article-title>. <source>BMC Microbiol.</source> <volume>21</volume> (<issue>1</issue>), <fpage>131</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12866-021-02139-w</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lanzillotta</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Mancuso</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Della-Torre</surname> <given-names>E.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Advances in the diagnosis and management of IgG4 related disease</article-title>. <source>BMJ</source> <volume>369</volume>, <elocation-id>m1067</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/bmj.m1067</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Wei</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Liang</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitis</article-title>. <source>Gut</source> <volume>71</volume> (<issue>5</issue>), <fpage>899</fpage>&#x2013;<lpage>909</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/gutjnl-2020-323565</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Differences in clinical characteristics of IgG4-related disease across age groups: a prospective study of 737 patients</article-title>. <source>Rheumatol. (Oxford)</source> <volume>60</volume> (<issue>6</issue>), <fpage>2635</fpage>&#x2013;<lpage>2646</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/rheumatology/keab090</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maehara</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Mattoo</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Mahajan</surname> <given-names>V. S.</given-names>
</name>
<name>
<surname>Murphy</surname> <given-names>S. J.</given-names>
</name>
<name>
<surname>Yuen</surname> <given-names>G. J.</given-names>
</name>
<name>
<surname>Ishiguro</surname> <given-names>N.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>The expansion in lymphoid organs of IL-4+ BATF+ T follicular helper cells is linked to IgG4 class switching <italic>in vivo</italic>
</article-title>. <source>Life Sci. Alliance</source> <volume>1</volume> (<issue>1</issue>), <elocation-id>e201800050</elocation-id>. doi: <pub-id pub-id-type="doi">10.26508/lsa.201800050</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maehara</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Moriyama</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Nakashima</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Miyake</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Hayashida</surname> <given-names>J. N.</given-names>
</name>
<name>
<surname>Tanaka</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>Interleukin-21 contributes to germinal centre formation and immunoglobulin G4 production in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz&#x2019;s disease</article-title>. <source>Ann. Rheumatic Dis.</source> <volume>71</volume> (<issue>12</issue>), <fpage>2011</fpage>&#x2013;<lpage>2019</lpage>. doi: <pub-id pub-id-type="doi">10.1136/annrheumdis-2012-201477</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maslinska</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Trojanowska</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Radzikowska</surname> <given-names>U.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>The role of igG4 in autoimmunity and rheumatic diseases</article-title>. <source>Front. Immunol.</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2021.787422</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miyajima</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Karashima</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Ogai</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Taniguchi</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Ogura</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Kawakami</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Impact of gut microbiome on dyslipidemia in Japanese adults: Assessment of the Shika-machi super preventive health examination results for causal inference</article-title>. <source>Front. Cell Infect. Microbiol.</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2022.908997</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mizoguchi</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Karashima</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Miyajima</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Ogura</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Kometani</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Aono</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>Impact of gut microbiome on the renin-aldosterone system: Shika-machi Super Preventive Health Examination results</article-title>. <source>Hypertens. Res</source>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41440-023-01334-7</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagase</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Karashima</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Tsujiguchi</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Tsuboi</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Miyagi</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Kometani</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Impact of gut microbiome on hypertensive patients with low-salt intake: Shika study results</article-title>. <source>Front. Med.</source> <volume>7</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmed.2020.00475</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pedregosa</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Varoquaux</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Gramfort</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Michel</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Thirion</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Grisel</surname> <given-names>O.</given-names>
</name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>Scikit-learn: machine learning in python</article-title>. <source>J. Mach. Learn Res.</source> <volume>12</volume>, <fpage>2825</fpage>&#x2013;<lpage>2830</lpage>.</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Plichta</surname> <given-names>D. R.</given-names>
</name>
<name>
<surname>Somani</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Pichaud</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Wallace</surname> <given-names>Z. S.</given-names>
</name>
<name>
<surname>Fernandes</surname> <given-names>A. D.</given-names>
</name>
<name>
<surname>Perugino</surname> <given-names>C. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Congruent microbiome signatures in fibrosis-prone autoimmune diseases: IgG4-related disease and systemic sclerosis</article-title>. <source>Genome Med.</source> <volume>13</volume> (<issue>1</issue>), <fpage>35</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13073-021-00853-7</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quast</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Pruesse</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Yilmaz</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Gerken</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Schweer</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Yarza</surname> <given-names>P.</given-names>
</name>
<etal/>
</person-group>. (<year>2013</year>). <article-title>The SILVA ribosomal RNA gene database project: Improved data processing and web-based tools</article-title>. <source>Nucleic Acids Res.</source> <volume>41</volume>, <fpage>D590</fpage>&#x2013;<lpage>D596</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gks1219</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Segata</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Izard</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Waldron</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Gevers</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Miropolsky</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Garrett</surname> <given-names>W. S.</given-names>
</name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>Metagenomic biomarker discovery and explanation</article-title>. <source>Genome Biol.</source> <volume>12</volume>, <fpage>R60</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/gb-2011-12-6-r60</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shetty</surname> <given-names>S. A.</given-names>
</name>
<name>
<surname>Marathe</surname> <given-names>N. P.</given-names>
</name>
<name>
<surname>Lanjekar</surname> <given-names>V. B.</given-names>
</name>
<name>
<surname>Ranade</surname> <given-names>D. R.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Reclassification of Eubacterium hallii as Anaerobutyricum hallii gen. nov., comb. nov., and description of Anaerobutyricum soehngenii sp. nov., a butyrate and propionate-producing bacterium from infant faeces</article-title>. <source>Int. J. Syst. Evol. Microbiol.</source> <volume>68</volume> (<issue>12</issue>), <page-range>3741&#x2013;3745</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1099/ijsem.0.003041</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shimizu</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Inazumi</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Sogawa</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Hyvarinen</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Kawahara</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Washio</surname> <given-names>T.</given-names>
</name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>A direct method for learning a linear non-Gaussian structural equation model</article-title>. <source>J. Mach. Learn Res.</source> <volume>12</volume>, <fpage>1225</fpage>&#x2013;<lpage>1248</lpage>.</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sva&#x10d;ina</surname> <given-names>M. K. R.</given-names>
</name>
<name>
<surname>Hall</surname> <given-names>J. W.</given-names>
</name>
<name>
<surname>Pritchard</surname> <given-names>J. F.</given-names>
</name>
<name>
<surname>Pritchard</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Ajroud-Driss</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Wolfe</surname> <given-names>G. I.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>The gut microbiome in intravenous immunoglobulin-treated chronic inflammatory demyelinating polyneuropathy</article-title>. <source>Eur. J. Neurol.</source> <volume>00</volume>, <fpage>1</fpage>&#x2013;<lpage>6</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/ene.15679</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tanaka</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Moriyama</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Nakashima</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Miyake</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Hayashida</surname> <given-names>J. N.</given-names>
</name>
<name>
<surname>Maehara</surname> <given-names>T.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>Th2 and regulatory immune reactions contribute to IgG4 production and the initiation of Mikulicz disease</article-title>. <source>Arthritis Rheumatism</source> <volume>64</volume> (<issue>1</issue>), <fpage>254</fpage>&#x2013;<lpage>263</lpage>. doi: <pub-id pub-id-type="doi">10.1002/art.33320</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tibshirani</surname> <given-names>R.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Regression shrinkage and selection <italic>via</italic> the lasso</article-title>. <source>J. R Stat. Soc</source> <volume>58</volume>, <fpage>267</fpage>&#x2013;<lpage>288</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.2517-6161.1996.tb02080.x</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsuji</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Koga</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Nonaka</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Nobusue</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Kawashiri</surname> <given-names>S. Y.</given-names>
</name>
<name>
<surname>Yamanashi</surname> <given-names>H.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>Identification of risk factors for elevated serum IgG4 levels in subjects in a large-scale health checkup cohort study</article-title>. <source>Front. Immunol.</source> <volume>14</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2023.1124417</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Umehara</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Okazaki</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Masaki</surname> <given-names>Y.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD</article-title>. <source>Mod. Rheumatol.</source> <volume>31</volume> (<issue>3</issue>), <fpage>529</fpage>&#x2013;<lpage>533</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/14397595.2021.1896283</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vlasova</surname> <given-names>A. N.</given-names>
</name>
<name>
<surname>Kandasamy</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Chattha</surname> <given-names>K. S.</given-names>
</name>
<name>
<surname>Rajashekara</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Saif</surname> <given-names>L. J.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Comparison of probiotic lactobacilli and bifidobacteria effects, immune responses and rotavirus vaccines and infection in different host species</article-title>. <source>Vet. Immunol. Immunopathol.</source> <volume>172</volume>, <fpage>72</fpage>&#x2013;<lpage>84</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.vetimm.2016.01.003</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vujkovic-Cvijin</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Sklar</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Natarajan</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Knight</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Belkaid</surname> <given-names>Y.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Host variables confound gut microbiota studies of human disease</article-title>. <source>Nature</source> <volume>587</volume>, <fpage>448</fpage>&#x2013;<lpage>454</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41586-020-2881-9</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vujkovic-Cvijin</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Swainson</surname> <given-names>L. A.</given-names>
</name>
<name>
<surname>Chu</surname> <given-names>S. N.</given-names>
</name>
<name>
<surname>Ortiz</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Santee</surname> <given-names>C. A.</given-names>
</name>
<name>
<surname>Petriello</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>The systemic anti-microbiota IgG repertoire can identify gut bacteria that translocate across gut barrier surfaces</article-title>. <source>Sci. Transl. Med.</source> <volume>14</volume> (<issue>658</issue>), <elocation-id>abl3927</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/scitranslmed.abl3927</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wallace</surname> <given-names>Z. S.</given-names>
</name>
<name>
<surname>Naden</surname> <given-names>R. P.</given-names>
</name>
<name>
<surname>Chari</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Choi</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Della-Torre</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Dicaire</surname> <given-names>J. F.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>The 2019 american college of rheumatology/European league against rheumatism classification criteria for igG4-related disease</article-title>. <source>Arthritis Rheumatol.</source> <volume>72</volume> (<issue>1</issue>), <fpage>7</fpage>&#x2013;<lpage>19</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/art.41120</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wallwork</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Perugino</surname> <given-names>C. A.</given-names>
</name>
<name>
<surname>Fu</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Harkness</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Choi</surname> <given-names>H. K.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>The association of smoking with immunoglobulin G4-related disease: a case-control study</article-title>. <source>Rheumatology</source> <volume>60</volume> (<issue>11</issue>), <fpage>5310</fpage>&#x2013;<lpage>5317</lpage>. doi: <pub-id pub-id-type="doi">10.1093/rheumatology/keab172</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Wei</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Sex disparities in clinical characteristics and prognosis of immunoglobulin G4&#x2013;related disease: a prospective study of 403 patients</article-title>. <source>Rheumatology</source> <volume>58</volume> (<issue>5</issue>), <fpage>820</fpage>&#x2013;<lpage>830</lpage>. doi: <pub-id pub-id-type="doi">10.1093/rheumatology/key397</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wastyk</surname> <given-names>H. C.</given-names>
</name>
<name>
<surname>Jakiela</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Sikora</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Osmenda</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Tykocinski</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Sk&#xf3;rka</surname> <given-names>K.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Gut-microbiota-targeted diets modulate human immune status</article-title>. <source>Cell</source> <volume>184</volume> (<issue>16</issue>), <fpage>4137</fpage>&#x2013;<lpage>4153.e14</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2021.06.019</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watanabe</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Yamashita</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Fujikawa</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Sakurai</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Kudo</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Shiokawa</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2013</year>). <article-title>Toll-like receptor activation in basophils contributes to the development of IgG4-related disease</article-title>. <source>J. Gastroenterol.</source> <volume>48</volume> (<issue>2</issue>), <fpage>247</fpage>&#x2013;<lpage>253</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00535-012-0626-8</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Willis</surname> <given-names>A. D.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Rarefaction, alpha diversity, and statistics</article-title>. <source>Front. Microbiol.</source> <volume>10</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2019.02407</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Song</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Qian</surname> <given-names>F.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Causal relationship between gut microbiota and autoimmune diseases: A two-sample mendelian randomization study</article-title>. <source>Front. Immunol.</source> <volume>12</volume>, <elocation-id>746998</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2021.746998</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yatsunenko</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Rey</surname> <given-names>F. E.</given-names>
</name>
<name>
<surname>Manary</surname> <given-names>M. J.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Human gut microbiome viewed across age and geography</article-title>. <source>Nature</source> <volume>486</volume>, <fpage>222</fpage>&#x2013;<lpage>227</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nature11053</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoon</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Shim</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Roles of sex hormones and gender in the gut microbiota</article-title>. <source>J. Neurogastroenterol. Motil.</source> <volume>27</volume> (<issue>3</issue>), <fpage>314</fpage>&#x2013;<lpage>325</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.5056/jnm20128</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoshikawa</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Watanabe</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Kamata</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Hara</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Minaga</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Kudo</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Intestinal dysbiosis and autoimmune pancreatitis</article-title>. <source>Front. Immunol.</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2021.621532</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>